1. Home
  2. EVC vs CMPX Comparison

EVC vs CMPX Comparison

Compare EVC & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entravision Communications Corporation

EVC

Entravision Communications Corporation

HOLD

Current Price

$3.13

Market Cap

233.8M

Sector

Industrials

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.13

Market Cap

752.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVC
CMPX
Founded
1996
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.8M
752.4M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
EVC
CMPX
Price
$3.13
$5.13
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$13.44
AVG Volume (30 Days)
344.6K
1.8M
Earning Date
11-04-2025
11-05-2025
Dividend Yield
6.33%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$420,178,000.00
N/A
Revenue This Year
$64.06
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.96
N/A
52 Week Low
$1.58
$1.33
52 Week High
$3.44
$5.86

Technical Indicators

Market Signals
Indicator
EVC
CMPX
Relative Strength Index (RSI) 65.24 53.30
Support Level $3.09 $4.83
Resistance Level $3.44 $5.32
Average True Range (ATR) 0.11 0.31
MACD -0.00 -0.08
Stochastic Oscillator 58.87 34.59

Price Performance

Historical Comparison
EVC
CMPX

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: